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Acute Respiratory Distress Syndrome and Prone Position in Covid-19 
 
Abstract 
Patients who develop severe Covid-19 disease can develop respiratory failure and 
subsequently Acute Respiratory Distress Syndrome (ARDS). However, it has to be noted that 
these patients may not follow the typical ARDS disease trajectory.  The causes of this paradox 
are complex and not yet fully understood, with the result that varying pathophysiological 
hypotheses have been proposed. This article describes ARDS in Covid-19 patients, the use of 
the conscious and unconscious prone position as an intervention to improve oxygenation.   
 
Key Points 
 Covid-19 can lead to respiratory failure and Acute Respiratory Distress Syndrome. 
 The cause of ARDS in Covid-19 is complex and not completely understood. 
 The high incidence of ARDS in Covid-19 patients has resulted in the use of the prone 
position being undertaken early  because for bor both conscious and unconscious 
patients it can improve oxygenation.  
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Covid-19 causes acute respiratory failure, with an estimated 10% of patients developing acute 
respiratory distress syndrome (ARDS), which is associated with a high mortality, of 
approximately 30- 40% despite advanced treatment [1]. In consequence, the rapid increase 
in critical care need, resulted in many hospitals, regions and countries coming close to, or 
being overwhelmed, by the unprecedented number of patients. As knowledge and 
understanding of this new Coronavirus advances, effective treatments measures have been 
increasingly identified. One of these, prone positioning, was not commonly used in critical 
care units prior to the Covid-19 pandemic [2-4], has revolutionised the treatment of both 
ventilated and non-ventilated patients. However, its re-introduction has confirmed that it 
should not be seen as a stand-alone measure, to be effective it needs to be a core component 
of a series of structured interventions. This chapter, explores the use of the prone position in 




The Covid-19 disease progression may range from mild to severe [5]. High numbers of 
hospitalised patients develop respiratory symptoms, with reported incidence of over 80% of 
patients needing oxygen therapy [6-7]. Patients with increasingly severe COVID-19 symptoms 
may go on to develop acute respiratory failure and subsequently Acute Respiratory Distress 
Syndrome (ARDS). It has to be noted that these patients may not follow the typical ARDS 
disease trajectory [8]. Within the literature, this has been described by the term ‘happy 
hypoxemia’ or ‘silent hypoxia’, when an individual has profound hypoxia caused by Covid-19, 
but does not have the proportional signs of respiratory distress [9-11]. In consequence, there 
has been a suggestion that the term CARDS (Covid-19 with ARDS) should be used instead of 
the traditional ARDS definition [8].  The causes of this paradox is complex and not yet fully 
understood, with the result that varying pathophysiological hypothesis have been proposed 
[8, 12].  
 
The phenotype theory hypothesis is that in severe COVID-19 disease, there is a systemic 
impact on the vascular endothelium, causing lung injury. Marini and Gattinoni [8] propose 
that in Covid-19, Type L and Type H phenotypes cause different variants of respiratory failure. 
Type L patients have a scattered ground glass appearance on chest X-ray, with good lung 
compliance and tend not to be Positive End Expiratory Pressure (PEEP) responsive. 
Contrastingly, individuals with Type H respiratory failure have extensive infiltrates with both 
atelectasis and oedema on chest X-ray, adding further complexity to the disease 
management. These patients have a lower lung compliance and are PEEP responsive. 
However, Marini and Gattinoni [8] describe the type L and H phenotypes as a continuum, with 
some stages and characteristics overlapping. They argue that during the early phases of 
respiratory failure, a complex process of pulmonary vascular dysregulation occurs, which 
instead of causing alveolar oedema, leading to hypoxemia, and a high minute volume 
ventilation, but they exhibit no signs of respiratory failure. As the pulmonary vascular 
dysregulation continues and extends, causing vasoplegia, the lungs become increasingly 
unable to regulate perfusion and maintain adequate ventilation. This exacerbates hypoxemia, 
causes deed space ventilation and hypercapnia, leading to ARDS.  
Jain and Doyle [12] dispute the above phenotype hypothesis and argue that the Type L 
phenotype relates to stage 2 or 3 of COVID-19 pneumonia. They propose a different 
pathophysiological process for the cause of severe hypoxia. They suggest that the SARS-CoV-
2 enters the type II alveolar epithelial cells binding to the spike protein of the ACE-2 receptor. 
This in turn leads to downregulation of the alveolar epithelium, allowing for ACE-1 to be have 
an unregulated effect on the pulmonary capillary endothelial cells. The level of protective 
ACE2-Ang-1-7-mas-R production is reduced, resulting in a harmful increase in the level of ACE 
1_AngII-ATI-R. Vasoconstriction in the pulmonary epithelium is caused by endotheliun-1. This 
causes a complex cascade effect, which results in endothelial nitric oxide being inhibited. The 
associated severe pulmonary vasoconstriction is unevenly distributed within the lungs, as the 
shunt fraction increases with the increasing hypoxia, the alveolar-capillary barrier is 
disrupted. The flooding of proteins, fibrin, cells and fluid into the alveolar space causes 
bilateral patchy group glass opacities noted on CT scan or Chest X-Ray. The development of 
pulmonary symptoms and rapid disease progression associated with COVID-19 may be linked 
to the ‘endothelial-epithelial’ interaction. Following alveolar-capillary membrane disruption, 
SARS-CoV-2 is able to enter the pulmonary capillary membrane via the pulmonary capillaries. 
The pulmonary endothelial cells become infected via the ACE-2 protein on the luminal 
surfaces, to assume a ‘proinflammatory / procoagulant’ phenotype. This accelerates 
apoptosis of alveolar epithelial and endothelial cells and causes a cytokine storm [13].  
The decision on when to intubate patients, remains largely subjective and based on 
practitioners experience and patient’s condition [14]. Mohlenkamp et al [15] found that 5-
15% of patients with Covid-19 require critical care and ventilatory support, with 17% patients 
developing ARDS [1]. ARDS was first described in critically ill patients in 1967 by Ashbaugh et 
al. [16]. However, it was not until 1994, then the first clinical definition was agreed by the 
International American European Consensus Conference (AECC) [17]. The Berlin Definition 
aimed to classify the severity of ARDS and to publish treatments and ventilatory strategies 
depending on the degree of hypoxemia [18].  ARDS is defined using the Berlin Criteria and is 
based on timing, imaging, evidence of oedema and oxygenation. ARDS, this is defined [19] as: 
‘an acute diffuse, inflammatory lung injury, leading to increased pulmonary vascular 
permeability, increased lung weight, and loss of aerated lung tissue…[with] hypoxemia 
and bilateral radiographic opacities, associated with increased venous admixture, 
increased physiological dead space and decreased lung compliance.’ 
 
ARDS is described as respiratory failure with an acute onset which affects both lungs and 
occurs within one week of either a clinical insult or deterioration in respiratory symptoms. 
Chest imaging reveals bilateral opacities not fully explained by effusions, lung collapse, and 
nodules. Respiratory failure not explained by cardiac failure and fluid overload and 
oxygenation: 
 Mild PaO2/FiO2 <39.9kPa (<300mmHg) with PEEP or CPAP >5cmH20 
 Moderate PaO2/FiO2 <26.6kPa (<200mmHg) with PEEP >5cmH20 
 Severe PaO2/FiO2 <13.3kPa (<100mmHg) with PEEP > 5cm20 
[19, 20, 21]. 
Limitations with the current ARDS definition, include that severity can be assessed on a single 
blood gas without prior standardisation of ventilator settings including PEEP which may affect 
oxygenation. In consequence, it is recommended that ventilator settings are optimised using 
tidal volumes of 6ml/kg of predicted body weight and a high PEEP level [22]. Furthermore, 
the time from optimising ventilator settings and assessing PaO2/FiO2 is deemed more clinical 
relevant in ARDS classification when measured 24 hours after ARDS onset [22].  
ARDS is an acute inflammatory lung condition not a disease, with multi-factorial causes and 
no proven drug treatments. Therefore, ARDS is always caused by an underlying pulmonary or 
extra-pulmonary condition. Pulmonary ARDS occurs when there is a direct insult to the lung 
damaging the alveolar epithelium, while extra-pulmonary ARDS is caused by an indirect lung 
injury due to inflammatory mediators damaging the vascular endothelium [23, 24]. 
Pulmonary ARDS can be caused by bacterial, viral or fungal pneumonia, aspiration of gastric 
contents, inhalation contusion, pulmonary contusion, and pulmonary vasculitis or near 
drowning. Extra-pulmonary ARDS can be triggered by non-pulmonary sepsis, non-cardiogenic 
shock, pancreatitis, major trauma, multiple transfusion or transfusion-related acute lung 
injury, severe burns or drug overdose [25-26].   
 
The majority of patients with Covid-19 who develop ARDS meet the Berlin Criteria [27]. In 
patients who develop ARDS, management includes using lung protection strategies: (low 
volume, low pressure ventilation). Initial ventilation strategies may include pressure 
controlled modes, with tidal volumes aimed at 6ml/kg using predicted body weight and 
plateau airway pressure <30cmH20. Initial ventilator settings may include a higher respiratory 
rate (20/min), with positive end expiratory pressure (PEEP). Early evidence suggests pressures 
may need to be lower than previously recommended [4]. There needs to be pre-oxygenation 
of patients prior to any intervention e.g. suctioning to prevent prolonged periods of 
desaturation. Moderate hypoxemia with Sp02 targets of >90% and Pa02 of >8kPa with 
permissive hypercapnia. 
The use of nitric oxide or nebulised prostacyclin if using a wet circuit has been noted to 
improve vasodilation and thus improve oxygenation and reducing airway pressures [4]. PEEP 
may be used to recruit collapsed alveoli; however, high PEEP should be avoided. Recruitment 
manoeuvres are used to improve oxygenation by providing brief inspiratory flow cycles to 
maximum plateau pressure and inflating collapsed alveoli. Recruitment manoeuvres tend to 
be used as a rescue therapy in severe refractory hypoxia or following accidental disconnection 
from the ventilator. The procedure remains controversial in routine care, as it provides a 
temporary increase in oxygenation which is not sustained, and therefore must only be 
performed by an experienced practitioner [28]. 
 
For patients who do not respond and become increasingly difficult to ventilate and oxygenate, 
the prone position may be considered. With Extra Corporeal Oxygenation Membrane (ECMO) 
services being limited in many settings during a pandemic, the prone position, may be used 
as an alternative in an attempt to improve oxygenation and optimise lung compliance [29].  
Conservative use of intravenous fluids and careful fluid balance monitoring, with the use of 
diuretics to remove excess fluid should be considered provided it is not detrimental to other 
organs.  
 
Considerations for Resource Limited Environments 
It is accepted that identifying and applying the internationally agreed ARDS definition in a 
resource limited setting may be difficult, due to limited availability of resources [30]. In these 
situations, it may be appropriate to use the Kigali modified ARDS definition and criteria (table 
xxx). The main difference relates to assessment of deteriorating respiratory deterioration, 
using the SpO2/FiO2 calculation [30]. 
 
Table 1: Similarities and differences between Kigali modified ARDS Definition and Berlin 
Definition of ARDS 
Kigali modified ARDS definition Berlin Definition of ARDS 
Acute onset affecting both lungs occurring 
within one week of: 
 Clinical insult #Deterioration in 
respiratory symptoms 
Acute onset affecting both lungs occurring 
within one week of: 
 Clinical insult  
 Deterioration in respiratory symptoms 
Chest X-ray or ultrasound showing: 
 Bilateral opacities not fully explained by 
effusions,  
 Lobar/lung collapse  
 Nodules.  
Chest imaging showing: 
 Bilateral opacities not fully explained by 
effusions 
 Lung collapse 
 Nodules. 
Respiratory failure not fully explained by 
cardiac failure or fluid overload 
Respiratory failure not explained by cardiac 
failure and fluid overload 
SpO2/FiO2 <315 
No Positive End Expiratory Pressure (PEEP) 
requirement  
Mild PaO2/FiO2 <39.9kPa (<300mmHg) 
with PEEP or CPAP >5cmH20 
Moderate PaO2/FiO2 <26.6kPa 
(<200mmHg) with PEEP >5cmH20 
Severe PaO2/FiO2 <13.3kPa (<100mmHg) 







The prone position involves repositioning the patient from the supine position onto their 
abdomen. It redistributes perfusion and improves ventilation/perfusion (VQ) matching, 
through maximising dorsal ventilation. This results in recruitment of the posterior lung 
segments reverse atelectasis and improved secretion clearance [28]. The prone position was 
first described in the literature in 1974, as a way to improve oxygenation [31]. Since that date, 
research has consistently shown that oxygenation can be improved in ventilated patients with 
ARDS by turning them into the prone position [32-35]. However, more recent studies have 
shown that prone position improves mortality in moderate to severe ARDS if undertaken 
early. The position needs to be maintained for 16-18 hours or more while using protective 
lung strategies [36]. This is a change from traditional practice, in which the prone position was 
solely used for ventilated patients, however, more recently, experience has shown a 
beneficial response to prone position by COVID-19 patients not yet requiring invasive 
ventilation [28]. Early recommendations are that proning patient on admission to ICU during 
the early phase of their disease may be beneficial and avoid more aggressive ventilation 
strategies. It can be used irrespective of the PF ratio [4]. Both conscious and unconscious 
prone position methods are described here. 
 
Conscious Prone Position 
For conscious patients with suspected or confirmed Covid-19 who requiring oxygen of >28% 
or basic respiratory support to achieve Sa02 92-96% (88-92% if high risk of hypercapnia 
respiratory failure) may gain benefit from the conscious prone position. If tolerated, this 
position can improve oxygenation, reducing the need for non-invasive ventilation (NIV). It has 
been found that is can delay and/or avert the need for intubation and mechanical ventilation 
[7, 28]. The current pandemic has also revealed that this is a simple and safe intervention that 
is suitable for use on general wards. 
 
If there is an improvement in Sa02 92-96% (88-92% if risk of hypercapnic respiratory failure) 
and no obvious distress, the prone position should continue, with a view of changing the 
patients position every 1-2 hours or longer if possible. When not in the prone position, the 
patient should be nursed in a 30-60 degree upright position. Vital signs including oxygen 
saturations and early warning scores should be monitored after every position change and 
oxygen titrated accordingly. If tolerated continued timed position changes can be used. A 
proposed regimen includes 30 minutes to 2 hours in the following positions lying fully prone 
with the bed flat, lying on their right side with the bed flat, sitting upright 30-60 degrees, lying 
on left side with the bed flat, prone position again and then repeated. The position should be 
discontinued if there is no improvement, the patient is unable to tolerate the position, the 
respiratory rate is >35, there is evidence of tiring and / or the use of accessory muscles [28]. 
If appropriate, the patient should be reviewed by critical care and assessment made regarding 
transfer into critical care. 
 
Absolute contraindications include respiratory distress (RR ≥ 35, PaCO2 ≥ 6.5, and / or 
accessory muscle use), the immediate need for intubation, haemodynamic instability (systolic 
blood pressure < 90mmHg) or arrhythmia, agitation or altered mental status, unstable 
spine/thoracic injury/recent abdominal surgery. Relative contraindications include facial 
injuries, neurological issues, morbid obesity, pregnancy (2/3rd trimesters) and pressure sores 
/ ulcers [28]. 
 
To turn a conscious patient into the prone position, it is important to explain the importance 
of the procedure to the patient, to provide reassurance, to improve oxygenation and reduce 
their chance of requiring invasive ventilation. Patients should be encouraged to remain in the 
prone position for as long as possible, ideally up to 18 hours per 24 hours. Patients must be 
assisted into and out of the prone position, and patients should not do this without assistance 
in case their oxygen levels drop during the turn. There are two ways the patient can position 
themselves in the prone position either from a sitting or lying position.  
 
Prone Position (Unconscious) 
During the pandemic, the increasing numbers of patients requiring prone positioning has led 
to the establishment of ‘proning teams’. Led by an Anaesthetist (or suitably trained advanced 
airway provider) the team is pre-trained and when necessary are able to turn a patient into 
the prone or supine position. Local and national guidelines and checklists are being developed 
to guide and support these teams [4]. 
 
Careful monitoring of patients is essential as there is some evidence that the prone position 
has been associated with a higher incidence of adverse effects than identified in patients 
placed in the supine position [37]. Potential complications include airway obstruction from a 
kinked or displaced ETT. Once in the prone position, frequent oral suctioning and mouth care 
is required as secretions may reduce the integrity of ETT securing devices. In addition, proning 
can lead to facial swelling causing retinal nerve compression, ETT ties becoming too tight and 
pressure ulcers. Electrodes for cardiac monitoring need to be applied posteriorly on the 
patients back and in the event of cardiac arrest the anterior/posterior placement of 
defibrillator pads/paddles should be used [38]. Enteral feeding can continue in the prone 
position; however, the procedure is high risk for vomiting and/or increased gastric residual 
vomiting [39-41]. Absolute contra-indications for prone position include spinal instability, 
unstable fractures, burns, open wounds, pregnancy, and recent tracheal surgery and raised 
intra-cranial pressure. Relative contra-indications include haemodynamic instability 
(including the use of vasopressors), cardiac pacemakers and abdominal surgery [37].  
Neuromuscular blocking agents may be required to maintain gaseous exchange, this reduces 
extrapulmonary resistance and ventilatory desynchrony which in turn results in improved 
oxygenation. Paralysis of the diaphragm allows for metabolic rest, reduced oxygen 
consumption and invasive control of breathing mechanic.26 Neuromuscular blockage may be 
required in patients with ARDS as this allows for less PEEP to maintain oxygenation, and 
reduced mortality. 
 
Once turned into the prone position patients may remain in this position for 12 to 16 hours 
per day [42]. In addition, patients may need to be placed into this position several times. 
Patients in the prone position should be nursed on a pressure relieving mattress to reduce 
pressure damage and periodically it will be necessary to change the position of the head and 
arms every 2-4 hours. To maintain the prone position, ventilated patients must be adequately 
sedated with the use of neuromuscular blockade [37, 43].  
 
It is important to note that critically ill patients are at high risk of developing malnutrition and 
sarcopenia [44]. Therefore, is accepted practice that early enteral feeding should be 
established unless contra-indicated, in addition, the enteral route is preferred over the 
parental route (e.g. Total Parental Nutrition (TPN) [41, 45]. However, there is an increased 
risk of gastric aspiration during repositioning, therefore, interruptions in the enteral feeding 
regimens have to occur when positioning a patient from supine to prone and vice-versa. 
Enteral feeding should be resumed once the patient has been re-positioning, NG tube position 
confirmed and vital signs recorded.  
 
Research into the impact of prone position on tolerance and gastrointestinal complications is 
still ongoing. De la Fuente et al’s [40] small scale study of enteral feeding tolerance in 
ventilated proned patients, concluded enteral feeding did not increase the risk of 
gastrointestinal problems. In contrast, Malhotra et al ([37] found patients in the prone 
position developed a higher incidence of vomiting and/ or increased in gastric residual 
volumes. As a result of their findings, Malhortra et al [37] recommend patients’ heads should 
be elevated at least 25° while receiving enteral feeding and that prokinetic drugs such as 
erythromycin may be appropriate.  
 
Conclusion: 
Nurses need understanding of the complex pathophysiological processes that arise from 
Covid-19 infection. However, as this chapter has indicated the pathophysiology associated 
with the development Covid-19 related ARDS is still being investigate. Nevertheless, the high 
incidence of ARDS in Covid-19 patients has resulted in recognition that use of the prone 
position undertaken early for both conscious and unconscious patients can improve 
oxygenation. It has been identified as an intervention that for some patients may reduce or 
avoid the need for invasive ventilation. Nevertheless, it has to be accepted that it poses 
potential risks and complications. Protocols, guidelines and training are essential to minimize 
the risk of adverse events during or after prone positioning. The Covid-19 pandemic is 
relatively new therefore, further research is needed before definitive guidelines and 
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